Buy or sell AbCellera Biologics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

View More Companies

AbCellera Biologics Stock

Antibody therapeutics

Founded

2012

Total Funding

$15.6M

About AbCellera Biologics Stock

AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.

Funding History

September 2013$0
August 2014$0
January 2017$0
April 2017$818K
September 2018$10.0M
March 2019$4.8M

Management

Co-Founder

Kevin Heyries

Co-Founder & Director

Véronique Lecault

Other Companies

DNA Script Logo
Learn More
Learn More
DNA Script
DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology.
$21.7MTotal Funding
Emerald Health Therapeutics Logo
Learn More
Learn More
Emerald Health Therapeutics
Emerald Health Therapeutics is a Health Canada Licensed Producer of medical cannabis.
$16.8MTotal Funding
Galera Therapeutics Logo
Learn More
Learn More
Galera Therapeutics
Therapeutic agents for preventing damage due to radiation treatment of cancer
$149MTotal Funding
Trigemina Logo
Learn More
Learn More
Trigemina
Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
$23.1MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from AbCellera Biologics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo